Substances | All subjects | Polypharmacy < 10 substances | Excessive polypharmacy ≥10 substances | ||||
---|---|---|---|---|---|---|---|
n | (%) | n | (%) | n | (%) | ||
C10AA | HMG CoA reductase inhibitors | 2479 | 63.5 | 999 | 60.8 | 1480 | 65.5 |
A02BC | Proton pump inhibitors | 2328 | 59.6 | 837 | 50.9 | 1491 | 66.0 |
C07AB | Beta blocking agents, selective | 2240 | 57.4 | 909 | 55.3 | 1331 | 58.9 |
B01AC | Platelet aggregation inhibitors excl. Heparin | 1952 | 50.0 | 762 | 46.4 | 1190 | 52.7 |
C09AA | ACE Inhibitors, plain | 1751 | 44.9 | 792 | 48.2 | 959 | 42.4 |
C03CA | Sulfonamides, plain | 1715 | 43.9 | 569 | 34.6 | 1146 | 50.7 |
C08CA | Dihydropyridine derivates | 1611 | 41.3 | 658 | 40.0 | 953 | 42.2 |
C09CA | Angiotensin II antagonists, plain | 1355 | 34.7 | 505 | 30.7 | 850 | 37.6 |
C03AA | Thiazides, plain | 1354 | 34.7 | 555 | 33.8 | 799 | 35.4 |
A11CC | Vitamin D and analogues | 1120 | 28.7 | 345 | 21.0 | 775 | 34.3 |